Our Services

Publications Planning & Medical Writing

High quality medical writing & project management support services

Read More

Process Audits

We find out if your processes & policies are achieving the desired results you need

Read More

Strategic Communications

Highly experienced at writing strategic communications & publications plans, & providing strategic advice

Read More

Medical Education & Training

Training & educational solutions that precisely match your needs & expectations

Read More

Health Economics Communications

One of the few agencies in the world with genuine health economics communications expertise

Read More

Creative Solutions

Conceptualise your ideas with on-line & off-line design, creative & production work

Read More

Evidence-Based Tools & Services

Our evidence-based tools & services help your organisation get ahead of the field

Read More

Education & Training Booklets

Education & training booklets that can also be customized for your organisation

Read More

Rx Communications...

making accurate, valuable information accessible

A Boutique Medical Communications Agency

Why choose Rx Communications?

  • The longest established and largest medical communications agency specialising in health economics and outcomes communications, publications and training
  • One of the most ethical and compliant medical communications agencies in healthcare today
  • A leader in innovative communications and publications, strategic planning and management
Why choose Rx

Customer Testimonials

Sadly, the confidential nature of our work means that our client testimonials are anonymous, but we still think it’s important for you know what they think of us anyway!

  • Thanks again. You did an awesome job with the poster!

    Communications Specialist

  • Let me express my special thanks to Josh and Hannah. You guys were great partners, we owe you a lot!

    Medical Director

  • Take it for granted, that I will be back once your help is needed.

    Health Economist

  • Your efforts were and are highly appreciated and demonstrated the ability of your organisation to work very well under pressure.

    Health Economist

  • Thank you so much for accommodating our aggressive timelines. From a medical writing perspective, I think the design layout looks crisp, eye catching, and professional.

    Author

  • The research was very thorough and the concepts were integrated in a very sophisticated manner. Also the writing style was very smooth and comprehensible and very easy for me to work from.

    Author

Latest news from the Health Economics & Outcomes World

  • 23andMe Gets OK from FDA to Report Breast Cancer...

    The U.S. Food and Drug Administration has given 23andMe, a genetic testing company that works directly with consumers, the green light to inform individuals of gene-related breast cancer risks. […]

  • Drugmaker Triples Price of Imbruvica after Dosage...

    While a group of cancer doctors were determined to find ways to reduce the treatment costs for Imbruvica, a blood cancer treatment, its maker tripled the price of the drug, according to a Washington […]

  • 2017 Drug Spending Grows Less than 1%

    Spending on drugs grew at only 0.6 percent last year, according to a recent report by IQVIA Institute for Human Data Science. The report, titled “2017 Medicine Use and Spending in the […]

Health Outcomes Communicator (HOC)

Read more

  • Do Outcome Measures in Pain Trials Hamper Drug Development?

    Chronic pain and other pain disorders are notoriously hard to treat, with approximately 40% of patients reporting insufficient relief from their medication. There is a huge unmet need for safe and effective drugs, referred to as analgesics, designed to treat pain as their primary function.

  • Rx Communications at the 52nd EASD Annual Meeting

    The annual European Association for the Study of Diabetes conference took place on the 12th–16th September 2016 at the ICM Messe Congress Centre in Munich, Germany. Munich is the largest city in German Bavaria and delegates attending the meeting also had the opportunity to enjoy the city’s culture, architecture and beautiful parks, as well as the local hospitality.

  • The New Cancer Drugs Fund Appraisal Process

    Since its launch 5 years ago, the Cancer Drugs Fund (CDF) is estimated to have helped over 95,000 patients gain access to lifesaving drugs and technologies. The CDF began as a temporary collaboration, between NICE and NHS England, that was extended in 2014 and due to end March 2016.

  • A Newcomer’s Viewpoint of the Diabetes UK Conference

    The Diabetes UK Professional Conference (DUK) is a major event, highly anticipated by its delegates. It has been running for over 20 years and for 2017 (April) it will take place in the Manchester Central Convention Complex.

  • mHealth: Current Opportunities and Challenges

    Services in many aspects of life are becoming virtual; shops, utility bills and even the faithful paperback book have now become digitised, with an increasing number of us adopting these new formats due to the convenience and cost savings they offer. In the last decade, healthcare spending in the OECD has increased from an average…

HOC Sign-Up

Get our Health Outcomes Communicator direct to your inbox – sign-up now!

Please note: we will not pass your details on to any third-parties